NCT04956939View on ClinicalTrials.gov

Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Parkinson Disease
Interventions
DRUG

Low dose levodopa

Low frequency is defined as ≤ 3 LD doses a day

DRUG

High dose levodopa

High frequency dosage is defined as ≥ 5 LD doses per day

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT04956939 - Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter